Sign inGet started

Gordon Christopher R

Insider CIK 1432313 · Q Director, 10% owner · ACHC Director · CERE Director, 10% owner · HCA Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CERE Cerevel Therapeutics Holdi D To issuer deriv2024-08-012024-08-0580,189— $00SEC↗
CERE Cerevel Therapeutics Holdi D To issuer2024-08-012024-08-0510,461— $00SEC↗
CERE Cerevel Therapeutics Holdi D To issuer2024-08-012024-08-053,282— $010,461SEC↗
CERE Cerevel Therapeutics Holdi D To issuer2024-08-012024-08-0565,679,781— $00SEC↗
CERE Cerevel Therapeutics Holdi A Award2024-06-052024-06-0710,461— $013,743SEC↗
CERE Cerevel Therapeutics Holdi P Buy2023-10-162023-10-185,480,052$22.81 $125.00M65,679,781SEC↗
CERE Cerevel Therapeutics Holdi A Award deriv2023-06-072023-06-0913,780— $013,780SEC↗
CERE Cerevel Therapeutics Holdi A Award2023-06-072023-06-093,282— $03,282SEC↗
CERE Cerevel Therapeutics Holdi J Other2023-06-072023-06-09432,627— $060,199,729SEC↗
CERE Cerevel Therapeutics Holdi A Award deriv2022-06-142022-06-1623,459— $023,459SEC↗
CERE Cerevel Therapeutics Holdi A Award deriv2021-06-102021-06-1442,950— $042,950SEC↗
CERE Cerevel Therapeutics Holdi P Buy2020-11-092020-11-12332,293$10.30 $3.42M60,632,356SEC↗
CERE Cerevel Therapeutics Holdi J Other2020-10-272020-10-2949,961,943— $050,300,063SEC↗
CERE Cerevel Therapeutics Holdi P Buy2020-10-272020-10-2910,000,000$10.00 $100.00M60,300,063SEC↗
ACHC Acadia Healthcare Company, A Award2018-05-032018-05-074,125— $012,328SEC↗
ACHC Acadia Healthcare Company, S Sale2017-08-222017-08-24998,438$50.69 $50.61M0SEC↗
ACHC Acadia Healthcare Company, S Sale2017-07-312017-08-022,453,764$51.65 $126.74M998,438SEC↗
ACHC Acadia Healthcare Company, A Award2017-05-252017-05-263,752— $08,203SEC↗
ACHC Acadia Healthcare Company, A Award2016-05-192016-05-232,840— $04,451SEC↗
ACHC Acadia Healthcare Company, S Sale2015-08-142015-08-182,351,137$80.47 $189.20M3,452,202SEC↗
ACHC Acadia Healthcare Company, J Other2015-08-102015-08-1242,778— $05,803,339SEC↗
Q Quintiles Transnational Ho S Sale2015-08-052015-08-072,396,792$77.37 $185.44M9,944,017SEC↗
Q Quintiles Transnational Ho J Other2015-07-302015-08-03148,796— $012,340,809SEC↗
Q Quintiles Transnational Ho S Sale2015-05-192015-05-212,971,840$64.85 $192.72M12,489,605SEC↗
Q Quintiles Transnational Ho J Other2015-05-132015-05-15168,337— $015,461,445SEC↗
ACHC Acadia Healthcare Company, A Award2015-02-262015-03-021,611— $01,611SEC↗
Q Quintiles Transnational Ho S Sale2014-11-102014-11-123,773,886$58.09 $219.23M15,629,782SEC↗
Q Quintiles Transnational Ho J Other2014-11-042014-11-06171,373— $019,403,668SEC↗
Q Quintiles Transnational Ho S Sale2014-03-262014-03-28570,682$50.31 $28.71M19,575,041SEC↗
Q Quintiles Transnational Ho S Sale2014-03-182014-03-203,579,373$50.31 $180.08M20,145,723SEC↗
Q Quintiles Transnational Ho J Other2014-03-122014-03-14225,170— $023,725,096SEC↗
HCA HCA Holdings, Inc. D To issuer2013-11-012013-11-055,328,218$46.92 $250.00M30,003,156SEC↗
HCA HCA Holdings, Inc. S Sale2013-11-012013-11-0514,580,887$46.92 $684.14M35,331,374SEC↗
HCA HCA Holdings, Inc. J Other2013-10-292013-10-31419,113— $049,912,261SEC↗
Q Quintiles Transnational Ho S Sale2013-05-142013-05-152,531,393$37.80 $95.69M23,950,266SEC↗
HCA HCA Holdings, Inc. S Sale2013-02-152013-02-2023,576,519$35.87 $845.69M50,331,374SEC↗
HCA HCA Holdings, Inc. J Other2013-02-112013-02-13308,233— $073,907,893SEC↗
HCA HCA Holdings, Inc. S Sale2012-12-142012-12-1815,033,063$33.00 $496.09M74,216,126SEC↗
HCA HCA Holdings, Inc. J Other2012-12-102012-12-12253,178— $089,249,189SEC↗